Enfusion, Inc. Class A Common Stock (ENFN)
11.14
+0.03 (0.27%)
NYSE · Last Trade: Apr 2nd, 7:15 PM EDT
ENFUSION INC - CLASS A (NYSE:ENFN) is a candidate for high growth investors. Here's why. Full fundamental and technical analysis of (NYSE:ENFN).
Via Chartmill · March 13, 2025

monday.com sees its Relative Strength Rating enter the elite 90-plus level.
Via Investor's Business Daily · February 11, 2025

One key metric to look for in a stock is an 80-plus Relative Strength Rating. Fastly stock cleared that benchmark Monday, with a jump to 85.
Via Investor's Business Daily · February 10, 2025

The Relative Strength (RS) Rating for Nutanix stock entered a new percentile Wednesday, with a rise from 66 to 81.
Via Investor's Business Daily · January 29, 2025

DigitalOcean stock had its Relative Strength Rating upgraded to 75 Monday — a nice improvement, but still shy of the preferred 80-plus score.
Via Investor's Business Daily · January 27, 2025

Computer software Freshworks stock saw its IBD SmartSelect Composite Rating jump to 96 Friday, up from 93 the day before.
Via Investor's Business Daily · January 24, 2025

Via Benzinga · March 13, 2024

Via Benzinga · January 30, 2024

The revised score means DigitalOcean stock currently tops 96% of all other stocks in terms of key performance metrics and technical strength.
Via Investor's Business Daily · January 23, 2025

Via Benzinga · January 17, 2025

Via Benzinga · January 2, 2025

Via Benzinga · December 30, 2024

Via Benzinga · December 19, 2024

One key metric to look for in a stock is an 80-plus Relative Strength Rating. Fastly stock cleared that benchmark Tuesday, with a jump to 84.
Via Investor's Business Daily · December 17, 2024

ENFN stock results show that Enfusion missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via InvestorPlace · August 6, 2024

ENFN stock results show that Enfusion beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 9, 2024

Equities have only become more expensive, but investors should still lookout for the most undervalued under-$10 stocks to buy in April.
Via InvestorPlace · April 4, 2024

U.S. equities market is rallying, but there are still interesting investments to make, especially for these strong-buy stocks under $10.
Via InvestorPlace · March 15, 2024

Via Benzinga · March 14, 2024

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter.
Via Benzinga · March 12, 2024
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the week of Feb. 26 through March 1.
Via Talk Markets · March 2, 2024

Goldman Sachs downgrades Enfusion from Neutral to Sell, lowers price target from $9 to $8, expects stock to be range-bound in 2024 with slower growth than Street estimates due to company-specific challenges. Analyst will watch for improvements to become more positive on the stock.
Via Benzinga · February 28, 2024

U.S. stocks closed slightly lower on Friday, but the S&P 500 closed out last year with a gain of 24.2%. The Dow closed the year with a 13.7% gain, while the Nasdaq Composite surged 43.4% to record its best year since 2020.
Via Benzinga · January 2, 2024

These top small-cap tech stocks are the ones to buy in for long-term returns as profits are evident from innovations.
Via InvestorPlace · December 6, 2023